They indicate there has been a consistent improvement in prescribing. The group provides advice on clinical evidence and cost-effectiveness, considering new and existing technologies. The group also works closely with the Health Innovation Partnership Board to streamline the pathway for new health innovations. Its pilot Innovative Medical Technology Overview (IMTO), for example, takes weeks rather than years to assess a new technology. It provides early intelligence of the nature, potential budget and service impact of health technologies in development. The NFP is represented by all 22 NHS Boards and the Scottish Government, as well as other stakeholders.